After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Ocular Therapeutix Inc is $1.63B. A total of 1.01 million shares were traded on the day, compared to an average of 1.13M shares.
In the most recent transaction, Heier Jeffrey S. sold 2,948 shares of OCUL for 9.01 per share on Nov 25 ’24. After the transaction, the Chief Scientific Officer now owns 269,059 company shares. In a previous transaction on Nov 25 ’24, Kaiser Peter sold 2,897 shares at 9.01 per share. OCUL shares that Chief Development Officer owns now total 213,087.
Among the insiders who sold shares, Nayak Sanjay disposed of 1,814 shares on Nov 25 ’24 at a per-share price of $9.00. This resulted in the Chief Strategy Officer holding 174,380 shares of OCUL after the transaction. In another insider transaction, Dugel Pravin sold 20,680 shares at $9.01 per share on Nov 25 ’24. Company shares held by the insider now total 791,793.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, OCUL has a high of $11.77 and a low of $2.14.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. OCUL’s latest balance sheet shows that the firm has $164.16M in Cash & Short Term Investments as of fiscal 2021. There were $58.98M in debt and $26.34M in liabilities at the time. Its Book Value Per Share was $2.25, while its Total Shareholder’s Equity was $88.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OCUL is Buy with a score of 5.00.
